2076975 2077203
최종편집 2021-04-17 06:23 (토)
National Pension Service reduces its stake in pharmaceutical companies for the third consecutive quarter
상태바
National Pension Service reduces its stake in pharmaceutical companies for the third consecutive quarter
  • Hyeokgi Lee, Newsmp
  • 승인 2021.04.08 11:11
  • 댓글 0
이 기사를 공유합니다

HanAll Biopharma 3.04%p↓in 1Q… Chong Kun Dang PharmaceuticalㆍHandok 2%↓
Dong-A ST back to 10%... Boryung PharmaceuticalㆍWhanin Pharmaceutical return to 5%    shareholders

The National Pension Service (NPS) has again sold a large stake in pharmaceutical companies.

Earlier, the National Pension Service expanded pharmaceutical companies’ stake until the first half of last year but lowered its stake significantly in the second half.

In the first quarter, the National Pension Service’s ownership of pharmaceutical companies decreased sharply. During this period, the ownership in five pharmaceutical companies were reduced by more than 1%p. 

According to the National Pension Service’s quarterly report on Stocks, etc. Held in Bulk, HanAll Biopharma’s stake in NPS plunged 3.04%p from 13.35% to 10.31% in 1Q.
Chong Kun Dang Pharmaceutical fell 2.09%p from 11.44% to 9.35%, and Handok dropped 2.06%p from 10.76% to 8.70%, down to a single digit.

JW Lifescience’s share of NPS also decreased by 2%p from 10.41% to 8.43%, and Bukwang Pharmaceutical also reduced by more than 1%p from 8.18% to 7.06%.

On the other hand, Dong-A ST’s ownership increased 1.04%p from 9.27% to 10.31%.
While NPS’s stake in Hanmi Pharmaceutical rose more than 1%p to 7.85%, Whanin Pharmaceutical and Boryung Pharmaceutical returned to 5% stockholders to 6.10% and 5.12%. 
 


댓글삭제
삭제한 댓글은 다시 복구할 수 없습니다.
그래도 삭제하시겠습니까?
댓글 0
댓글쓰기
계정을 선택하시면 로그인·계정인증을 통해
댓글을 남기실 수 있습니다.